Arash Kardan

Arash Kardan, M.D., is an Associate Professor of Radiology and Medicine at Baylor College of Medicine. He serves as Division Chief of Nuclear Medicine and Molecular Imaging and holds leadership roles in radiation safety committees across multiple institutions, including Baylor St. Luke's Medical Center and Harris Health System. Dr. Kardan's extensive clinical expertise includes Nuclear Medicine, Nuclear Cardiology, and PET/CT imaging, with a focus on theranostics and neuroendocrine tumors.

Education and Training: Dr. Kardan earned his MD from Universidad Autónoma de Guadalajara (1999). He completed postdoctoral training at New York Medical College and residencies/fellowships at institutions such as Massachusetts General Hospital/Harvard Medical School, Stanford University, and the NIH T32 Advanced Molecular Imaging Fellowship.

Research Interests: His work spans diagnostic/therapeutic nuclear medicine, molecular imaging, PET/MRI integration, neuroendocrine tumor treatment, and novel radiotracer development. He actively contributes to clinical guidelines (e.g., NCCN Neuroendocrine Tumor Guidelines) and medical education milestones.

Awards: Dr. Kardan has received the NIH T32 Award (2006–2008), Houstonia Magazine's Top Doctors recognition (2024), and multiple patient-choice awards (Vitals.com). His research has led to advancements in imaging techniques for oncology and rheumatoid arthritis.

Professional Roles: Beyond Baylor College of Medicine, he directs nuclear medicine services at Ben Taub General Hospital and collaborates with institutions like the Neuroendocrine Research Foundation. His work includes innovative imaging protocols for conditions like cardiac amyloidosis and melanoma sentinel node localization.